Tower Research Capital LLC (Trc) Vaxxinity, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.62 - $0.86 $35 - $49	58 Added 0.46%	12,640 $9,000
Q4 2023 Feb 13, 2024	BUY	$0.7 - $1.31 $1,801 - $3,370	2,573 Added 25.71%	12,582 $10,000
Q3 2023 Nov 14, 2023	BUY	$1.25 - $3.0 $10,061 - $24,147	8,049 Added 410.66%	10,009 $13,000
Q2 2023 Aug 14, 2023	SELL	$1.73 - $2.79 $22,493 - $36,275	-13,002 Reduced 86.9%	1,960 $4,000
Q1 2023 May 09, 2023	BUY	$1.43 - $4.24 $20,823 - $61,742	14,562 Added 3640.5%	14,962 $34,000
Q4 2022 Feb 10, 2023	BUY	$1.31 - $2.62 $524 - $1,048	400 New	400 $1,000
Q2 2022 Aug 15, 2022	BUY	$1.55 - $6.95 $1,849 - $8,291	1,193 New	1,193 $1,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.